An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination

Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other pathogens with pandemic potential requires safe, protective, inexpensive, and easily accessible vaccines that can be developed and manufactured rapidly at a large scale. DNA vaccines can achieve these criteria...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Dengning, Jin, Rui, Byagathvalli, Gaurav, Yu, Huan, Ye, Ling, Lu, Chao-Yi, Bhamla, M. Saad, Yang, Chinglai, Prausnitz, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2021
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609327/
https://www.ncbi.nlm.nih.gov/pubmed/34670842
http://dx.doi.org/10.1073/pnas.2110817118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609327/
https://www.ncbi.nlm.nih.gov/pubmed/34670842
http://dx.doi.org/10.1073/pnas.2110817118

Ejemplares similares